These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10389972

  • 21. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H, Welter H, Kraetzl WD, Steffl M, Meyer HH, Schams D, Berisha B.
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [Abstract] [Full Text] [Related]

  • 22. Expression of neutrophil collagenase (MMP-8) in Jurkat T leukemia cells and its role in invasion.
    Kim MH, Albertsson P, Xue Y, Nannmark U, Kitson RP, Goldfarb RH.
    Anticancer Res; 2001 Sep; 21(1A):45-50. PubMed ID: 11299777
    [Abstract] [Full Text] [Related]

  • 23. Proteases and cancer invasion: from belief to certainty. AACR meeting on proteases and protease inhibitors in cancer, Nyborg, Denmark, 14-18 June 1998.
    Blasi F, Stoppelli MP.
    Biochim Biophys Acta; 1999 Jan 29; 1423(1):R35-44. PubMed ID: 9989212
    [No Abstract] [Full Text] [Related]

  • 24. [Protein tyrosine kinase inhibitor genistein suppresses in vitro invasion of HT1080 human fibrosarcoma cells].
    Yan C, Han R.
    Zhonghua Zhong Liu Za Zhi; 1999 May 29; 21(3):171-4. PubMed ID: 11776827
    [Abstract] [Full Text] [Related]

  • 25. The invasive behaviour of prostatic cancer cells is suppressed by inhibitors of tyrosine kinase.
    Skogseth H, Larsson E, Halgunset J.
    APMIS; 2006 Jan 29; 114(1):61-6. PubMed ID: 16499663
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.
    Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nübe O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P.
    Nat Med; 1999 Oct 29; 5(10):1135-42. PubMed ID: 10502816
    [Abstract] [Full Text] [Related]

  • 27. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
    Hirata M, Sato T, Tsumagari M, Shimada A, Nakano H, Hashizume K, Ito A.
    Biol Reprod; 2003 Apr 29; 68(4):1276-81. PubMed ID: 12606436
    [Abstract] [Full Text] [Related]

  • 28. The novel targets for anti-angiogenesis of genistein on human cancer cells.
    Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, Liu HS, Cheng HL, Hsu PY, Chow NH.
    Biochem Pharmacol; 2005 Jan 15; 69(2):307-18. PubMed ID: 15627483
    [Abstract] [Full Text] [Related]

  • 29. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P, Soeltl R, Krell HW, Collins K, O'Donoghue M, Schmitt M, Krüger A.
    Anticancer Res; 1999 Jan 15; 19(5B):3809-16. PubMed ID: 10628317
    [Abstract] [Full Text] [Related]

  • 30. [Effect of decidual cell conditioned media on invasion-related gene expression of ovarian tumor cell line COC1].
    Zhu JH, Pang ZJ, Chen SL, Xing FQ.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul 15; 24(7):752-5. PubMed ID: 15257893
    [Abstract] [Full Text] [Related]

  • 31. Effect of intrafollicular indomethacin injection on gonadotropin surge-induced expression of select extracellular matrix degrading enzymes and their inhibitors in bovine preovulatory follicles.
    Li Q, Jimenez-Krassel F, Kobayashi Y, Ireland JJ, Smith GW.
    Reproduction; 2006 Mar 15; 131(3):533-43. PubMed ID: 16514196
    [Abstract] [Full Text] [Related]

  • 32. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
    Badier-Commander C, Verbeuren T, Lebard C, Michel JB, Jacob MP.
    J Pathol; 2000 Sep 15; 192(1):105-12. PubMed ID: 10951407
    [Abstract] [Full Text] [Related]

  • 33. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
    Schmalfeldt B, Prechtel D, Härting K, Späthe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W, Lengyel E.
    Clin Cancer Res; 2001 Aug 15; 7(8):2396-404. PubMed ID: 11489818
    [Abstract] [Full Text] [Related]

  • 34. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
    Collins HM, Morris TM, Watson SA.
    Br J Cancer; 2001 Jun 15; 84(12):1664-70. PubMed ID: 11401321
    [Abstract] [Full Text] [Related]

  • 35. Matrix degradation in liver: a role in injury and repair.
    Arthur MJ.
    Hepatology; 1997 Oct 15; 26(4):1069-71. PubMed ID: 9328336
    [No Abstract] [Full Text] [Related]

  • 36. Proteolytic enzymes in proliferation and neoplastic metastases formation.
    Gołaszewski Z, Gacko M, Chyczewska E, Chyczewski L, Myćko G, Worowski K.
    Rocz Akad Med Bialymst; 1997 Oct 15; 42 Suppl 1():48-59. PubMed ID: 9337523
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profile.
    Kolkhorst V, Stürzebecher J, Wiederanders B.
    J Cancer Res Clin Oncol; 1998 Oct 15; 124(11):598-606. PubMed ID: 9860288
    [Abstract] [Full Text] [Related]

  • 38. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity.
    de Veas RG, Schweigerer L, Medina MA.
    J Cancer Res Clin Oncol; 1995 Oct 15; 121(5):275-8. PubMed ID: 7768964
    [Abstract] [Full Text] [Related]

  • 39. Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer.
    Rha SY, Noh SH, Kim TS, Yoo NC, Roh JK, Min JS, Kim BS.
    Int J Mol Med; 1999 Aug 15; 4(2):203-12. PubMed ID: 10402490
    [Abstract] [Full Text] [Related]

  • 40. Homocysteine is a potent inhibitor of human tumor cell gelatinases.
    Chavarría T, Rodríguez-Nieto S, Sánchez-Jiménez F, Quesada AR, Medina MA.
    Biochem Biophys Res Commun; 2003 Apr 04; 303(2):572-5. PubMed ID: 12659857
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.